Illuccix’s broad approval is supported by robust clinical data, including the largest Ga-68-based PSMA data set from the VISION trial 6. The approval of Illuccix® in France has the potential to ...

A ground-breaking urine test for prostate cancer is gaining ground, promising a future where early detection could become as ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

The Ohio Valley is set to host its inaugural "Blue Tie Gala," an event organized by Brave Men Inc. to promote prostate cancer awareness and support. The gala, s ...

Quoc-Dien Trinh, MD, MBA, discusses a sub-analysis of the phase 3 ARANOTE trial, focusing on Black patients with metastatic ...

The breakthrough could potentially save thousands of lives. The post Prostate cancer could be detected early by urine test ...

A pivotal trial of an electronic artificial urinary sphincter could herald the future of treating incontinence.

Comedian Milton Jones reveals he has prostate cancer and cancels UK tour dates - The 60-year-old also announced he would be ...

A study involving researchers from Karolinska Institutet indicates that prostate cancer can be diagnosed at an early stage ...

Sophia Kamran, MD, discusses how salvage therapy after biochemical recurrence may improve outcomes for patients with prostate ...

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...